- Home
- NUAI vs CATX Comparison
NUAI vs CATX Comparison
Compare NUAI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUAI | CATX |
|---|---|---|
| Founded | N/A | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 403.6M | 355.0M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NUAI | CATX |
|---|---|---|
| Price | $5.52 | $2.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $11.00 | ★ $12.11 |
| AVG Volume (30 Days) | ★ 5.8M | 1.1M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.89 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $885,400.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 66.18 | N/A |
| 52 Week Low | $0.41 | $1.96 |
| 52 Week High | $9.45 | $6.16 |
Technical Indicators
Market Signals| Indicator | NUAI | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 51.00 | 36.77 |
| Support Level | $3.89 | $2.25 |
| Resistance Level | $6.37 | $2.96 |
| Average True Range (ATR) | 0.44 | 0.16 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 38.28 | 10.94 |
Price Performance
Historical ComparisonAbout NUAI New Era Energy & Digital Inc.
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.